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Abstract
Background: WHO now recommends test-based management of malaria across all transmission settings. The accuracy of
rapid diagnostic test (RDT) and the outcome of treatment based on the result of tests will influence acceptability of and
adherence to the new guidelines.
Method: We conducted a study at the Kintampo hospital in rural Ghana to evaluate the performance of CareStart, a HRP-2
based RDT, using microscopy as reference. We applied IMCI treatment guidelines, restricted ACT to RDT-positive children
and followed-up both RDT-positive (malaria) and RDT-negative (non-malaria) cases over 28 days.
Results: 436 children were enrolled in the RDT evaluation and 391 (children with haemoglobin .8.0 gm/dl) were followed-
up to assess treatment outcomes. Mean age was 25.4 months (s.d. 14.6). Sensitivity and specificity of the RDT were 100.0%
and 73.0% respectively. Over the follow-up period, 32 (18.5%) RDT-negative children converted to positive, with 7 (4.0%) of
them presenting with fever. More children in the non-malaria group made unscheduled visits than children in the malaria
group (13.3% versus 7.7%) On all scheduled follow-up visits, proportion of children having a temperature higher than that
recorded on day 0 was higher in the non-malaria group compared to the malaria group. Reports of unfavourable treatment
outcomes by caregivers were higher among the non-malaria group than the malaria group.
Conclusions: The RDT had good sensitivity and specificity. However a minority of children who will not receive ACT based
on RDT results may develop clinical malaria within a short period in high transmission settings. This could undermine
caregivers’ and health workers’ confidence in the new guidelines. Improving the quality of management of non-malarial
febrile illnesses should be a priority in the era of test-based management of malaria.
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Introduction
IMCI guidelines promoted the presumptive treatment of
malaria for all febrile illnesses in children in high transmission
settings. [1,2] This approach contributed to over-diagnosis and
over-emphasis on malaria to the neglect of other causes of
childhood febrile illnesses [3,4,5,6,7]. Chloroquine and sulpha-
doxine-pyrimethamine, the cheap and safe antimalarial drugs that
justified the presumptive approach are no longer effective. Since
they are now replaced with the more expensive artemisinin-based
combination therapy (ACT), there has been a move towards the
targeted use of the ACTs [8,9,10,11]. The World Health
Organisation (WHO) has revised malaria treatment guidelines,
restricting the use of ACT to only parasitologically-confirmed
cases [12]. As availability of microscopy is very limited in most
places in sub-Saharan Africa, rapid diagnostic tests (RDTs) are the
means through which the confirmation of malaria diagnosis will be
achieved. The accuracy, reliability and outcome of treatment
based on results of RDT will be a major determinant of the
acceptability and adherence to the new guidelines. [13,14].
The use of RDT would more clearly delineate non-malaria
febrile illnesses and it is argued that this will lead to improved
management of such cases [15,16,17,18,19,20]. Conversely, RDTs
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are not perfect tools and false results could undermine the
confidence of clinicians and lead to a lack of adherence to the new
guidelines.[21,22] False-negative results present the greater
challenge as they may lead to delay in the initiation of treatment
and possible deterioration in the condition of the child.[7].
As the incidence of malaria declines, increasingly more children
will present to health facilities with low levels of parasitaemia. At
low levels of parasitaemia, the probability of a false-negative result
is higher and this could cause delay in the initiation of treatment.
On the other hand, in high transmission settings a positive RDT
result does not necessarily rule out bacterial or viral co-infections,
as symptomatic malaria parasitaemia is not uncommon. [23,24]
In the era of presumptive treatment, nearly all children who
presented with febrile illness received an antimalarial. In addition
to clearing parasites in children with malaria, this ‘‘opportunistic
presumptive treatment’’ probably prevented new malaria infec-
tions through post treatment prophylaxis in all children. It is
hypothesised that restricting ACTs to RDT-positive cases would
lead to increased frequency of malaria in children since a large
number of children would be denied this inadvertent prophylactic
benefit and make them prone to malaria sooner and more
frequently than children who receive antimalarials. [25]
The over-emphasis on malaria over the years has been at the
expense of attention to non-malarial febrile illnesses. Very little is
known about the aetiology and epidemiology of non-malaria fevers
in sub-Saharan Africa. [26] With the use of RDTs, a substantial
proportion of febrile illness in children will likely be diagnosed as
non-malaria fevers. The treatment outcome in this group of
children, who will be denied ACT, is likely to influence the
acceptability of the new policy by health workers and caregivers
who are used to receiving antimalarial prescriptions for all febrile
illness in children.
In Ghana, the management of fever in under-five children has
for many years been based on guidelines in the Integrated
Management of Childhood Illnesses (IMCI). [1] The Ghana
National Malaria Control Programme (NMCP) is in the process of
revising the national guidelines for the treatment of malaria based
on the revised WHO recommendations. The confirmation of
malaria in Ghana will be done by RDTs as microscopy is still not
widely available. Several HRP-2 based RDTs including CareStart
p.f are being considered for roll out nationally. Studies in Africa
show considerable variability in sensitivity and specificity of HRP 2
antigen detection tests. [20,26,27] There is also very limited
evidence on the clinical outcomes of febrile children managed on
the basis of RDT results. We therefore conducted a prospective
cohort study to evaluate the accuracy and reliability of CareStart
p.f. for the diagnosis of malaria in Ghana, and the treatment
outcome in both RDT positive (malaria) and RDT negative (non-
malaria) cases. We evaluated CareStart p.f. because it was the
RDT that the NMCP was considering deploying in the country at
the time of initiating this study.
Methods
The protocol for this study is available as supporting
information; see Protocol S1.
Study site
The study was conducted in Kintampo North municipality of
Ghana which lies within the forest-savannah transition belt and
has malaria transmission all year round. The entomological
inoculation rate was estimated at 269 infective bites per person per
year. Peak incidence of malaria (8.6 per child per year) occurs in
children aged 12–35 months. [28,29] The study was undertaken
in the out-patients department (OPD) of the Kintampo Municipal
Hospital from February 2009 to February 2010.
Study procedures
Caregivers residing within 15 km of the hospital who presented
with children aged 3–60 months, with complaints that included
fever, either on presentation (temperature.37.5uC) or within the
previous 48 hours, were requested to take part in the study. After
individual informed consent had been obtained, 50 mg of capillary
blood was taken from all children to estimate haemoglobin using
HemocueTM, perform rapid test for malaria using CareStartTM,
and prepare thin and thick blood smears for microscopy. Filter
paper samples were taken for PCR analysis. Children were
excluded if they had any of the IMCI danger signs or other signs of
severe disease. Children with Hb,8 gm/dl were also excluded as
a precautionary measure given uncertainty about the accuracy of
the RDT and the practice of restricting ACT to RDT-positive
cases at the time of initiating the study. Children were also
ineligible if they were enrolled in other clinical studies. Children
were enrolled as and when they presented at the clinic and were
found to be eligible. This occurred within normal OPD working
hours (0800–1400 hrs), Mondays to Fridays.
All the children were assessed by a study physician using a
standard morbidity assessment questionnaire that ensured com-
prehensive IMCI-based case management. After clinical assess-
ment, 5 mls of venous blood was taken under aseptic conditions
for blood culture. Malaria was diagnosed and treated with an
ACT only when RDT was positive. Other medications were
prescribed according to identified co-morbidities. RDT-negative
cases were managed on the basis of the conditions that were
diagnosed using IMCI case management guidelines.
The first doses of all prescribed medications were administered
under direct observation by a study nurse. Caregivers were
educated on the correct procedure for administering the
remaining medications at home. The follow-up schedule and the
procedures were explained to caregivers prior to leaving the
facility. All children (irrespective of RDT results) were followed-up
in the clinic on days 1, 2, 3, 7, 14 and 28 post-treatment.
Caregivers who failed to show up by mid-day of a scheduled
appointment were followed-up to their places of residence. The
reason for non-attendance was ascertained and assistance was
offered to enable attendance at the clinic within 24 hours.
Caregivers were reimbursed for their transportation costs. On
each follow-up visit, a standard morbidity questionnaire was
administered by a trained research assistant. Caregivers were
asked to indicate whether they considered the condition of the
child to be ‘‘improving’’, ‘‘unchanged’’, ‘‘worsening’’ or with ‘‘new
illness’’. On days 1, 7, 14, 28 post-treatment and on all
unscheduled visits, blood sample was taken for RDT and blood
smear microscopy. Whenever a caregiver reported ‘‘unchanged’’,
‘‘worsening’’ or ‘‘new illness’’, the child was further assessed by the
study clinician.
Notwithstanding the scheduled appointments, caregivers were
advised to bring their children to the hospital at any time that the
condition of the child did not improve or when new symptoms
developed (unscheduled visits).
Sample size
The primary end point for estimating the sample size was the
sensitivity of RDTs to diagnose malaria. We assumed that the
RDTs should have at least 95% sensitivity to be useful. To
estimate a sensitivity of 95% with a 95% confidence limit of +/2
3%, 203 true positive cases of malaria were required. Our second
assumption was that the proportion of participants clearing fever
Restricting ACT to RDT Positive Malaria
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by day 3 post-treatment would be 95% in the RDT positive cohort
and 85% in the RDT negative cohort. The loss to follow up by day
3 would be ,5%. To have 80% power to detect this difference
between the two cohorts with 95% significance, 170 (159 plus
allowance for loss to follow-up) participants were needed in each
cohort.
Laboratory analysis
All blood smear microscopy was performed at the clinical
laboratory of the Kintampo Health Research Centre using
standard staining and examination techniques. Parasites were
counted against 200 white blood cells and slides declared negative
only after 100 fields had been examined. Two microscopists
independently read slides while discordant slides were read by a
third microscopist. The agreement between two of the microsco-
pists was taken as the final result. All microscopists were blinded to
the results of RDTs. Due to logistic constraints, PCR analyses
were limited to cases where there were conversions from RDT
negative to positive during follow-up. All the RDTs used in the
study were stored between 21uC and 35uC, consistent with the
recommendations of the manufacturer. Blood culture was done
using BACTEC blood culture system, with subculture of positive
vials and gram staining for identification.
The clinical laboratory at KHRC participates in the external
quality assessments schemes provided by the College of American
Pathologist, UK National External Quality Assessment Scheme
(UK-NEQAS) and the National Institute for Communicable
Diseases in South Africa.
Data management and analysis
All data were double-entered in a database and verified/cleaned
using FoxPro version 6. Analyses were performed using STATA
version 10. The results of microscopy were used as reference to
assess the accuracy and reliability of RDT results. Treatment
outcomes were assessed on the basis of (1) changes in RDT result
(from that obtained on day 0) within the 28-day follow-up period
and the correlation with clinical outcome, (2) frequency of
unscheduled visits, (3) caregiver perception of clinical outcome,
(4) occurrence of fever (axillary temp.37.5uC) and (5) the
reduction (from baseline) in haemoglobin level. Caregiver
perception of clinical outcome was assessed on the basis of the
condition of the child as reported by the caregiver during follow-
up visits. Caregiver perception was considered favourable when
improvement in the condition of the child relative to the time of
initial presentation was reported and unfavourable when the
condition was reported to be ‘‘unchanged’’, ‘‘worsened’’ or with
‘‘new illness’’. The treatment outcomes were compared between
the two groups. However, given that the natural history and
treatment outcomes of malaria and non-malaria fevers are likely to
be inherently different, the relative risks of various outcomes were
not calculated.
Ethical considerations
Written informed consent was obtained from all caregivers
before enrolment. The protocol for the study was approved by the
Institutional Ethics Committee of the Kintampo Health Research
Centre, the Ethics Review Committees of the Ghana Health
Service and the London School of Hygiene and Tropical
Medicine. The study was conducted in accordance with the
principles of Good Clinical Practice. The study is a component of
the trial registered in the clinical trials registry under
NCT00832754.
Results
A total of 1224 children aged 3 months 259 months were
screened and 436 children were enrolled (Figure 1) The reasons
for exclusion were residence beyond 15 km from the hospital
(616), presenting with at least one IMCI danger sign (89) and
refusal to participate (83). All excluded children were treated using
the standard treatment guidelines. Of the 436 that were enrolled,
45 had haemoglobin less than 8 gm/dL and were excluded from
protocol-based clinical assessment and follow-up. They were
however included in the assessment of the accuracy of RDT at
day 0.
The mean age was 25.4 months (S.D. = 14.6) and only 44.3% of
the children had fever (axillary Temp.37.5uC) at the time of
enrolment. The children who had a RDT positive result were
slightly older, more likely to have axillary temperature.37.5uC
(P,0.01) and anaemic compared to children who had a RDT
negative result (P,0.01). No child in the RDT negative group had
malaria parasitaemia. The geometric mean parasite density was
6861/ul (range 31–1,518,575/ul). (Table 1)
Blood culture was positive for 37 (9.5%) out of 391 children, and
the isolates included Staphylococcus aureus (24), Non-typhoid
Salmonella (8), E.coli (1), S. pneumonia (1), Acinetobacter sp (1), Proteus
sp (1) and Pseudomonas sp (1). Although a slightly higher proportion
of RDT-negative children had a positive culture than RDT-
positive children (11.6% versus 7.8%; p = 0.37), the difference was
not statistically significant (Table 1).
Diagnosis at presentation
Acute respiratory infection (ARI) (63.4%), malaria (55.5%),
diarrhoea (16.9%) and skin infections (14.1%) were the leading
diagnosis established among the 391 children at enrolment. About
a third (28.6%) of them had both ARI and malaria. A higher
proportion of RDT-negative children had ARI at enrolment than
in RDT-positive children (78.0% versus 51.8%; p,0.01). There
were no statistically significant differences in the proportion of
children presenting with diarrhoea or skin diseases between the
RDT-negative and RDT-positive children (Table 1). Unspecified
acute febrile illness was the diagnosis in 8.1% of RDT-negative
children.
Antibiotic prescription
A higher proportion of RDT-negative children were given
antibiotics than RDT-positive children (93.6% vs 61.9%; p,0.01).
Children diagnosed with ARI (95.2% vs 42.7%: p,0.01), skin
diseases (87.3% vs 74.1%; p = 0.07) or diarrhoea (80.3% vs 75.1%:
p = 0.37) were more likely to be prescribed an antibiotic. However,
those diagnosed with either malaria (61.8 % vs 97.3%: p,0.01), or
unspecified acute febrile illnesses (57.1% vs 76.7%: p = 0.09) were
less likely to be prescribed an antibiotic.
Accuracy and reliability of CareStart
The sensitivity of CareSart for the diagnosis of malaria on day
zero was 100.0%. Specificity was however 73.0% (95% C.I. 67%–
78%) while positive and negative predictive values were 75.7%
(95% C.I. 70%–81%) and 100% respectively. The false positive
error rate at day zero was 27% (95% C.I. 19%–30%). Over the
28-day follow-up period, the rate of RDT conversion from positive
to negative was markedly slower than blood smear parasite
clearance. As a result, RDT false positive error rates were over
50% by day 7 and 14, and 43.5% on day 28 post-treatment
(Figure 2). However, children presenting with fever and having a
positive RDT result during the scheduled follow-up days were
Restricting ACT to RDT Positive Malaria
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Figure 1. Profile of children attending and outcome of rapid test for malaria.
doi:10.1371/journal.pone.0034073.g001
Table 1. Demographic and baseline clinical characteristics of children.
Variable RDT Positive RDT Negative P-value
Sex Male 143 (54.4%) 93 (53.8%) 0.09
Female 120 (45.6%) 80 (46.2%
Age (months) Mean (s.d.) 26.8 (14.0) 23.1 (15.1) 0.01
#12mths 54 (20.5%) 57 (33.0%)
.12mths 209 (79.5%) 116 (67.1%)
Temperature (C) Mean (s.d.) 37.8 (1.3) 37.0 (0.9) ,0.01
Fever at presentation Yes 152 (57.8%) 41 (23.7%)
Hemoglobin (gm/dl) Mean (s.d.) 9.6 (1.9) 11.3 (1.3) ,0.01
Blood Smear Positive 199 (75.7%) 0.0 (0.0%) ,0.01
Bacterial growth Positive 17 (7.8%) 20 (11.6%) 0.37
Clinical diagnosis at enrolment ARI 113 (51.8%) 135 (78.0%) ,0.01
Diarrhoea 31 (14.2%) 35 (20.2%) 0.12
Skin infections 27(12.4%) 28 (16.2%) 0.28
Category of drugs prescribed ACT 217 (99.5%) 0 (0.00%) ,0.01
Analgesic 207(95.0%) 166 (96.0%) 0.64
Antibiotics 135 (61.9%) 162 (93.6%) ,0.01
doi:10.1371/journal.pone.0034073.t001
Restricting ACT to RDT Positive Malaria
PLoS ONE | www.plosone.org 4 April 2012 | Volume 7 | Issue 4 | e34073
16.7% on day 1, 3.5% (day 2), 5.6% (day 7), 5.2% (day 14) and
10.6% (day 28).
Changes in RDT results and correlation with clinical
outcome
Over the 28-day follow-up period, 32 (18.5%) children who
tested RDT negative on day 0, converted to RDT positive. The
conversions were 6 (3.5%), 7 (4.0%), 8 (5.2%) and 11 (10.4%) on
days 1, 7, 14 and 28 respectively. All 32 were microscopy and
PCR negative on day 0. In 7 (4.0%) of these children, conversion
to RDT positive was associated with fever (axillary tempera-
ture.37.5C), giving a malaria incidence of 0.53 per person year.
In 5 of them, the children were presented on unscheduled visits,
while in the remaining 2, the caregivers reported ‘‘new illness’’ on
their day 28 visit. In all 7 cases, conversion to RDT positive was
confirmed by positive microscopy and they were diagnosed with
uncomplicated malaria. No case of severe malaria or death was
recorded.
Unscheduled visits
Forty (10.2%) children made an unscheduled visit during the
28-day follow up period as a result of caregiver’s perception of
adverse outcome. A higher proportion of children with non-
malaria illnesses made unscheduled visits on account of febrile
illness than children diagnosed with malaria (13.3% vs 7.8%). The
sensitivity, specificity and positive predictive value of RDT for the
diagnosis of malaria on these unscheduled visits were 100%,
65.5% and 47.3% respectively. Diagnoses other than malaria
made at these unscheduled visits included ARI (47.5%) and
diarrhoea (10.0%). In 6 (15.0%) cases, both malaria and acute
respiratory infections were diagnosed.
Caregiver perception of clinical outcome
No caregiver reported a worsening of the condition of the child
compared to the status at enrolment. However, the proportion of
caregivers who reported the emergence of ‘‘new illness’’ or
‘‘unchanged’’ condition increased from 5.1%, (day 1) to 14.7%
(day 28). On all scheduled follow-up days (except on day 14), the
proportion of caregivers reporting less favourable treatment
outcomes was higher in the non-malaria group compared to the
malaria group (Table 2).
Fever clearance (temperature.37.5 C)
The proportions of children having fever were 6.1%, 2.3%,
1.8%, 1.5%, 2.6% and 4.6% on days 1,2,3,7, 14 and 28 post-
treatment respectively. On day 3, a higher proportion of children
in the non-malaria group had fever than children in the malaria
group (2.89% versus 1.82%). On all scheduled follow-up days, a
higher proportion of children in the non-malaria group had
temperature above values recorded on day 0 (Table 3).
Post-treatment change in haemoglobin
The proportions of children with haemoglobin lower than that
recorded at enrolment were 61.1%, 52.1%, 39.9% and 32.7% on
day 1, 7, 14 and 28 post-treatment respectively. The proportion of
children having a reduction in Hb level on day 1 post treatment
compared to day 0 was higher in the malaria group than in the
non-malaria group (46.8% vs 72.4%). In contrast, the proportion
of children having lower Hb levels at day 28 post-treatment
compared to day 0 Hb levels was higher in the non-malaria group
than the malaria group (44.8% versus 23.4%) (Table 4). On
average, children who had non-malaria illnesses experienced a
negative change in haemoglobin at day 28 post-treatment than
children who had malaria illness (20.05 versus +0.87) (Figure 3).
Discussion
This study was primarily powered to test the accuracy of the
RDT and the treatment outcomes were secondary end-points. The
comparative analyses of treatment outcomes were exploratory and
should be interpreted with caution. The findings will require
further investigation in appropriately-powered studies. Notwith-
standing these limitations however, a pattern of comparatively
unfavourable outcomes in children in the non-malaria group
emerges that raises concern about their recovery when managed
using current guidelines, and possibly the safety of restricting ACT
to RDT positive cases in high malaria transmission setting. First,
the RDT negative to positive conversion rate of 18.5% over a 28–
day period appears high when compared to 0.8% found in a
cohort of children (average age of 5years) in a study in a region of
low malaria transmission in Uganda. [30] The malaria incidence
of 0.53 per person year (extrapolated from a 28–day follow-up
period) was also higher than the 0.42 and 0.45 that were observed
in the Ugandan study and in another study in south-central
Tanzania [31] where transmission is relatively lower than in
Kintampo. Unlike in the Uganda study however, ours and the
Tanzanian study did not have background cohorts (outside of the
febrile children enrolled in the study) against which the general
incidence of malaria over the same period could be compared. In
the Uganda study, the incidence of malaria in the seven days
following a negative smear in a febrile patient was significantly
lower than the incidence of malaria over the entire course of the
study (0.42 vs. 1.01 per person year, p = 0.0003). However since
the risk of malaria is unlikely to be uniform over the period after a
febrile episode, it is conceivable that a longer period of follow-up
would have witnessed increased cases of malaria, particularly in
the non-malaria group that was denied ACT on day 0 because
their RDT results were negative. In a cohort of children in
Uganda, 50% of children who had asymptomatic parasitaemia
become symptomatic malaria within 30 days [32]. This has
similarly been found in studies in other sub-Saharan African
countries [33].
If previous IMCI guidelines (antimalarial for all fever cases) had
been applied in these cohorts of children however, nearly all of
them would have been given an antimalarial. For those who did
not have malaria (RDT negatives), such antimalarial would have
Figure 2. Proportion of children positive for malaria by RDT
and blood smear microscopy and false positive error rates of
RDT on day 0 and during scheduled follow-up days.
doi:10.1371/journal.pone.0034073.g002
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offered some prophylactic benefit that would have conferred some
protection from malaria for possibly 4–12 weeks depending on the
half-life of the partner antimalarial in the ACT that is given. On
the other hand unnecessary ACT use would have exposed the
partner drug to selective mutation of falciparum resistance strains.
[34]
In the Ugandan and Tanzanian studies [30,31] as well as our
study, all the cases of malaria that occurred during the follow-up
period among initially RDT-negative children were identified
early and managed before the development of complications. We
believe however that the assurance of safety this provides is
misleading as the measures instituted in these studies to ensure
follow-up of the children cannot be replicated under routine
conditions. The children enrolled in the studies were selected using
criteria that maximised the possibility of follow-up and close
monitoring e.g. living within a defined distance of the facility. In
the real-life setting, the policy of restricting ACT to RDT-positive
will be applied irrespective of where in the community the child
will be coming from, and some children with false negative malaria
diagnosis may report late to the facility for review and could
develop severe disease.
The decision to deploy test-based management of malaria
therefore needs to be carefully evaluated, within the context of
local levels of malaria transmission. In high-transmission settings
the risk of malaria and delayed treatment could outweigh the
advantages of targeted treatment. Health worker perceptions that
children who are denied ACT tend to return to the clinic sooner,
would undermine the confidence with which they adhere to the
revised test-based treatment guidelines.
In Tanzania, a study among severely-ill children (2 months –
13 years) that used different brands of HRP-2 RDT found
sensitivities levels of between 96.4% and 98.2%. [35] Critically
important were the false-negative results among patients in whom
levels of parasitaemia were in excess of 2000/microL, a
phenomenon similarly observed in a study in Ethiopia where
RDT missed three cases (out of 34) in which parasitaemia were
between 40–60,000/microL. [36] In both instances, genetic
heterogeneity of the HPR-2 expression was considered as a
Table 2. Caregivers’ perception of clinical outcome in RDT negative (non-malaria) and RDT positive (malaria) children.
Day of visit Caregiver perception RDT negative (non-malaria)* RDT positive (malaria)*
Day 1 Unsatisfactory 10 (5.8%) 10 (4.6%)
Satisfactory 163 208
Day 2 Unsatisfactory 17 (9.8%) 12 (5.5%)
Satisfactory 156 206
Day 3 Unsatisfactory 17 (9.8%) 9 (4.1%)
Satisfactory 156 209
Day 7 Unsatisfactory 13 (7.5%) 15 (6.9%)
Satisfactory 160 203
Day 14 Unsatisfactory 16 (9.3%) 24 (11.0%)
Satisfactory 157 194
Day 28 Unsatisfactory 30 (17.4%) 27 (12.4%)
Satisfactory 142 190
*Column percentages
doi:10.1371/journal.pone.0034073.t002
Table 3. Change in body temperature (from day 0) in RDT negative (non-malaria) and RDT positive (malaria) children.
Day of visit Direction of temperature change RDT negative (non-malaria)* RDT positive (malaria)*
Day 1 Increase 37 (21.6%) 19 (8.9%)
Same or decrease 134 194
Day 2 Increase 32 (18.7%) 20 (9.2%)
Same or decrease 139 197
Day 3 Increase 31 (17.9%) 16 (7.3%)
Same or decrease 142 202
Day 7 Increase 23 (13.4%) 18 (8.3%)
Same or decrease 149 199
Day 14 Increase 32 (18.8%) 15 (6.9%)
Same or decrease 138 201
Day 28 Increase 28 (16.8%) 16 (7.4%)
Same or decrease 139 200
*Column percentages
doi:10.1371/journal.pone.0034073.t003
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possible explanatory factor. Although the clinical outcome of
patients in this category was not reported in both studies, generally
the clinical consequences of such false-negative results, particularly
in a population of severely-ill children could be profound.
Exploring the reasons for false-negative results, in the presence
of high-levels of parasitaemia should be a research priority. This
includes the occurrence of the prozone effect [37,38,39] and or
microscopically false-negative results.
The over-emphasis on malaria has been at the expense of
diagnosis and effective treatment of other causes of childhood
fevers in malaria high transmission settings. [26,40] Consequently,
very little is known about the definitive diagnosis and outcome of
the management of non-malaria febrile illnesses. In this study, care
was standardized using IMCI-based case management guidelines.
However the pattern of less favourable outcomes in children with
non-malaria illnesses suggests that care for these children through
this strategy was probably less than optimal.
While a comparison on the basis of giving (malaria cohort) or
denying ACT (non-malaria cohort) has been presented, it is
important to acknowledge that the two groups of children
represent different pathologies. For this reason, it has been
suggested that statistical testing of observed differences between
the two groups is not appropriate, and observed trends in the
malaria cohort cannot be used as a comparator against which to
assess trends in the non-malaria cohort. [31]. However we believe
this position is arguable for the following reasons: (1) Observed
differences between the two cohorts could be explained by factors
other than differences in underlying pathologies alone e.g. attitude
and or competence of attending health workers, appropriateness of
current guidelines, availability of appropriate diagnostic tools (2)
The pattern of treatment outcome in non-malaria illnesses in
malaria endemic areas is less well-studied and no standards are
currently available to define the state or time point of
improvement (3) the pattern of treatment outcome in malaria is
well-described and likely to form a part of the expectations of
health workers and caregivers. It is conceivable that the pattern of
less favourable outcome (in the non-malaria cohort) may have
been present even in the era of presumptive malaria treatment but
did not attract attention because almost all fevers were considered
as malaria. As the policy of test-based malaria management
continues to be rolled out, the challenge of how to appropriately
manage non-malarial febrile illnesses would become important.
This would include how caregivers perceive the outcome of care
for children who are denied ACT on account of RDT-negative
tests. Test-based management of malaria will more clearly
delineate non-malarial febrile illnesses but improved guidelines
and better diagnostics will be required to guarantee appropriate
management of such cases. [14,26]
The 9.5% rate of positive blood culture among out-patient
children in this study is lower than rates of between 21.3% and
26% among hospitalised patients in two studies in Kumasi,
Ghana. [41,42,43]. It is however similar to rates obtained among
hospitalised children in Tanzania (9.4%) and Kenya (7.1%).
[44,45] As in the present study, non-typhoid Salmonella and S.
aureus were the major organisms isolated as in the Kenyan and
Tanzanian studies. This contrast to the findings of some other
studies in the same countries where bacteraemia rates among
outpatients were much lower and other organisms other than non-
typhoid Salmonella and S. aureus dominated. [44,45]
Although the RDT used in this study showed a perfect
sensitivity of 100%, in about 1 out of 4 cases, the positive results
on day 0 were false positives. Misleading interpretation of such
Table 4. Changes in haemoglobin (from day 0) in RDT negative (non-malaria) and RDT positive (malaria) on scheduled follow up
days.
Day of visit Direction of change RDT negative (non-malaria)* RDT positive (malaria)*
Day 1 Decrease 79 (46.8%) 157 (72.4%)
Same or increase 90 60
Day 7 Decrease 79 (46.5%) 121 (56.5%)
Same or increase 91 93
Day 14 Decrease 76 (45.2%) 76 (35.7%)
Same or increase 92 137
Day 28 Decrease 73 (44.8%) 50 (23.5%)
Same or increase 90 163
*Column percentages
doi:10.1371/journal.pone.0034073.t004
Figure 3. Mean change in haemoglobin (from day 0) for RDT
positives (malaria) and negatives (non-malaria) children.
doi:10.1371/journal.pone.0034073.g003
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positive RDT results have the potential to lead to the withholding
of life-saving antibiotics. [46] The persistence of HRP-2 antigen in
the blood leading to high false-positive results during follow-up is
consistent with well-documented characteristics of HRP-2 based
RDTs [24,47,48] 41 A false-positive error rate of over 50%, two to
three weeks after an index event highlights the need for targeted
training for clinicians in the correct interpretation and application
of RDT results. The false positive RDT results due to the
persistence of HRP-2 antigen can be overcome with PLDH based
RDTs. However the co-incidence of malaria parasitaemia along
with other infections is more complex to address in high
transmission settings. Economic analyses that make the case that
using RDT is cost-effective must take into account the quantity of
ACTs that would be wasted in such situations. The deployment of
RDTs in test-based malaria management should be accompanied
by intensive clinical training that emphasise the message that using
RDT does not preclude the need for full clinical assessment in the
management of childhood febrile illnesses.
Two studies funded by the ACT Consortium (www.
actconsortium.org ) that are specifically-designed to address the
question of safety in restricting ACT to RDT-positive cases in
under-five children in high and low transmission settings are
currently underway. The findings of these studies will further
clarify the issues raised in this study.
Conclusions
The brand of RDT tested has good sensitivity and specificity.
However a minority of children who will not receive ACT based
on RDT result may develop clinical malaria within a short period
in high transmission settings. This could undermine caregivers’
and health workers’ confidence in the new guidelines. Improving
the quality of management of non-malarial febrile illnesses should
be a priority in the era of test-based management of malaria.
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